A genetic basis for human susceptibility to West Nile virus

Trends in Microbiology

Volumn 14, Issue 7, 2006, Pages 287-289

  Diamond, Michael S ^a   Klein, Robyn S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE CCL4; CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ALLELE; BIRD; BLOOD BRAIN BARRIER; DISEASE SEVERITY; ENCEPHALITIS; FEVER; FLAVIVIRUS; FORENSIC MEDICINE; GENE DELETION; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HORSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MENINGITIS; MOSQUITO; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RNA TRANSCRIPTION; RNA VIRUS; SHORT SURVEY; VERTEBRATE; VIRUS INFECTION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; WEST NILE VIRUS INFECTION;

ALLELES; ANIMALS; CHEMOKINES, CC; CHEMOKINES, CXC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MUTATION; RECEPTORS, CCR5; RISK FACTORS; WEST NILE FEVER; WEST NILE VIRUS;

WEST NILE VIRUS;

EID: 33745509649     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2006.05.004     Document Type: Short Survey

References (15)

1. Nash D., et al. The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344 (2001) 1807-1814
2. Glass W.G., et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 203 (2006) 35-40
3. Wang T., and Fikrig E. Immunity to West Nile virus. Curr. Opin. Immunol. 16 (2004) 519-523
4. + T cells in the control of West Nile virus infection. J. Virol. 78 (2004) 8312-8321
5. Glass W.G., et al. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 202 (2005) 1087-1098
6. Perelygin A.A., et al. Positional cloning of the murine flavivirus resistance gene. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 9322-9327
7. Yakub I., et al. Single nucleotide polymorphisms in genes for 2′-5′-oligoadenylate synthetase and RNase L in patients hospitalized with West Nile virus infection. J. Infect. Dis. 192 (2005) 1741-1748
8. + T cell recruitment and control of West Nile virus encephalitis. J. Virol. 79 (2005) 11457-11466
9. Liu R., et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86 (1996) 367-377
10. Zhou Y., et al. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160 (1998) 4018-4025
11. Fatkenheuer G., et al. Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat. Med. 11 (2005) 1170-1172
12. Martinson J.J., et al. Global distribution of the CCR5 gene 32-basepair deletion. Nat. Genet. 16 (1997) 100-103
13. Hummel S., et al. Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons. Genes Immun. 6 (2005) 371-374
14. Sabeti P.C., et al. The case for selection at CCR5-Delta32. PLoS Biol. 3 (2005) e378
15. Mecsas J., et al. Evolutionary genetics: CCR5 mutation and plague protection. Nature 427 (2004) 606